[ ReThink Medical raises $3M in Series A ]
ReThink Medical has raised $3 million in Series A funding.
Founded in 2010, ReThink Medical l’s solution changes the reactive nature of health care specific to heart failure by drastically reducing costs and significantly improving the quality of life for the patients affected by this disease. ReThink’s focus is to disrupt the standard of care that costs the US over $30 billion and affects more than 5 million people in the US annually.
The new financing will be used to fund ReThink Medical’s clinical trials and for further investment in its proprietary technology platform. Bob Brownell, managing director at EMP, will join ReThink Medical’s board of directors.
|City||San Francisco, California|
|Founder / CEO||Reza Naima|
|Investors||Emergent Medical Partners|
|Previous Investors||SkyDeck | Berkeley|